TAC Regimen

Known as: TAC, Taxotere-Adriamycin-Cytoxan Regimen 
An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer. It includes the drugs docetaxel (Taxotere… (More)

Topic mentions per year

Topic mentions per year

2005-2017
012320052017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
MicroRNAs (miRNAs) have critical roles in regulating cancer cell survival, proliferation and sensitivity to chemotherapy. The… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 2
  • figure 3
Is this relevant?
2015
2015
A chemotherapy regimen of docetaxel, doxorubicin and cyclophosphamide (TAC) has been accepted as a standard care because of their… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2015
2015
STUDY QUESTION Is there any in vitro evidence for or against ovarian protection by co-administration of a GnRH agonist with… (More)
Is this relevant?
2013
2013
BACKGROUND Modified-release tacrolimus (TAC) is a new, once-daily oral formulation of the established immunosuppressive agent TAC… (More)
  • figure 1
  • table 1
  • figure 4
  • figure 2
  • figure 3
Is this relevant?
2012
2012
The aim of this study was to evaluate preoperative tumour expression of NAD(P)H:quinone oxidoreductase 1… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
2010
2010
The aim of this study was to compare two regimens of chemotherapy in patients with breast cancer, including FAC (doxorubicin… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 4
Is this relevant?
2008
2008
PURPOSE To estimate the cost effectiveness of TAC (docetaxel, doxorubicin, and cyclophosphamide) compared with FAC (fluorouracil… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2008
2008
BACKGROUND Combining the Bcl-2 down-regulator oblimersen with cytotoxic treatment leads to synergistic antitumor effects in… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • table 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND The aim of the study was to analyse the toxicity and health related quality of life (HRQoL) of breast cancer patients… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2006
2006
The introduction of taxanes in the armamentarium against breast cancer in the 1990s has been one of the landmarks in the… (More)
Is this relevant?